5 Common But Embarrassing Symptoms You Should Definitely Talk to Your Doctor About



sign and symptoms of tuberculosis in english :: Article Creator

History Of Tuberculosis

Tuberculosis is a highly contagious disease caused by the bacteria Mycobacterium tuberculosis (M. Tuberculosis), which is believed to be present in nature for at least 15,000 years.

Mycobacterium tuberculosis is a pathogenic bacterial species in the family Mycobacteriaceae and the causative agent of most cases of tuberculosis - Illustration Credit: Tatiana Shepeleva / Shutterstock

Tuberculosis has been known to mankind since ancient times. It is believed that the genus Mycobacterium was present in the environment about 150 million years ago, and an early variant of M. Tuberculosis originated in East Africa about 3 million years ago. A growing pool of evidence suggests that the current strains of M. Tuberculosis is originated from a common ancestor around 20,000 – 15,000 years ago.

Studies on Egyptian mummies (2400 – 3400 B.C) revealed the presence of skeletal deformities related to tuberculosis, such as characteristic Pott's deformities. However, no evidence of tuberculosis was found in Egyptian papyri. The description of tuberculosis was initially found in India and China as early as 3300 and 2300 years ago, respectively. Moreover, tuberculosis was mentioned in the Biblical books using the Hebrew word 'schachepheth' to describe tuberculosis.

In the Andean states, the first pre-Columbian evidence of tuberculosis was observed in Peruvian mummies, indicating the presence of the disease before the European colonization of South America.

Tuberculosis was well documented in the Ancient Greece as 'Phthisis' or 'Consumption'. In Book I, Of the Epidemics, Hippocrates described the symptoms of Phthisis, which are very similar to the common characteristics of tubercular lung lesions.

A Greek physician, Clarissimus Galen, who became the physician of the Roman Emperor Marcus Aurelius in 174 AD, described the symptoms of tuberculosis as fever, sweating, coughing, and blood-stained sputum. He also suggested that fresh air, milk, and soy beverages should be effective treatments for tuberculosis.

In Roman times, tuberculosis was mentioned by Celso, Aretaeus of Cappadocia, and Caelius Aurelianus. However, it remained unrecognized at that time. After the decline of the Roman Empire in the 5th century, a vast pool of archeologic evidence of tuberculosis was found throughout Europe, indicating that the disease was widespread in Europe during this time.

In the Middle Ages, a new clinical form of tuberculosis was described as scrofula, a disease of cervical lymph nodes. In England and France, the disease was known as 'king's evil', and there was a popular belief that it could be treated with the 'royal touch'. The practice of the 'royal touch' established by English and French kings continued for several years. Queen Anne was the last British monarch to employ this method for healing.

A French surgeon, Guy de Chauliac, proposed the first medical intervention for treating tuberculosis. He advised the removal of the scrofulous gland as a treatment option.

An Italian physician, Girolamo Fracastoro, first described the contagious nature of tuberculosis clearly in the 16th century.

In 1679, Francis Sylvius provided the exact pathological and anatomical description of tuberculosis in his book 'Opera Medica'. In 1720, a British physician, Benjamin Marten, first described the infectious origin of tuberculosis in his publication entitled 'A new theory of Consumption. In the 17th and 18th centuries, the terms 'Consumption' and 'phthisis' were used to describe tuberculosis.

In 1819, a French physician, Theophile Laennec, identified the pathological signs of tuberculosis, including consolidation, pleurisy, and pulmonary cavitation. He also identified that M. Tuberculosis can infect the gastrointestinal tract, bones, joints, nervous systems, lymph nodes, genital and urinary tracts, and skin (extra-pulmonary tuberculosis), in addition to the respiratory tract (pulmonary tuberculosis).

Johann Schonlein first coined the term 'tuberculosis' in 1834. At the beginning of the 19th century, there was a scientific debate about the exact etiology of tuberculosis. Many theories existed at that time, describing the disease as infectious, hereditary, or a type of cancer.

In 1843, Philipp Friedrich Hermann Klencke, a German physician, experimentally produced the human and bovine forms of tuberculosis for the first time by inoculating extracts from a miliary tubercle into the liver and lungs.

In 1854, sanatorium cure for tuberculosis was introduced by Hermann Brehmer, a tuberculosis patient, in his doctoral thesis. He mentioned that a long-term stay in the Himalayan mountains helped cure his tuberculosis.

A French military surgeon, Jean-Antoine Villemin, experimentally proved the infectious nature of tuberculosis in 1865. He inoculated a rabbit with fluid taken from a tuberculous cavity of a person who died of tuberculosis.

A German physician and microbiologist, Robert Koch, successfully identified, isolated, and cultured the tubercle bacillus in animal serum. Afterward, he produced animal models of tuberculosis by inoculating the bacillus. In 1882, his groundbreaking work was published in the Society of Physiology in Berlin.

Discovery of diagnostic methods

In 1907 – 1908, Clemens von Pirquet and Charles Mantoux developed the tuberculosis skin test, in which tuberculin (extracts of the tuberculosis bacillus) is injected under the skin, and the body's reaction is measured. In recent years, advancements in tuberculosis diagnosis have included interferon-gamma release assays, which are whole-blood tests to detect M. Tuberculosis infection.

Tuberculosis bacillus in the lungs. Tuberculosis is caused by the bacterium Mycobacterium tuberculosis. Image Credit: Juan Gaertner / Shutterstock

Discovery of vaccine

A pioneering work toward the prevention of tuberculosis was made by Albert Calmette and Jean-Marie Camille Guerin, who developed the Bacille Calmette-Guérin (BCG) vaccine in 1921.

Discovery of therapeutic agents

Besides preventive vaccines, a major breakthrough in tuberculosis treatment occurred with the discovery of antibiotics. In 1943, a tuberculosis antibiotic streptomycin was developed by Selman Waksman, Elizabeth Bugie, and Albert Schatz. Afterward, Selman Waksman received the Nobel prize in 1952.

In the recent era, four antibiotics namely isoniazid (1951), pyrazinamide (1952), ethambutol (1961), and rifampin (1966) are used to effectively treat tuberculosis. With the improvement in diagnostic procedures, therapeutic interventions, and preventive strategies, the World Health Organization (WHO) has committed to eradicate M. Tuberculosis by the year 2050.        

Further Reading

World Tuberculosis Day 2025: Symptoms, Causes, Risk Factors Of This Infectious Disease

One of the most dreaded infectious diseases, tuberculosis, often starts slowly with an occasional cough that lingers longer than expected. However, the mild discomfort may later turn into a deep, persistent cough that refuses to go away. As it progresses, it brings along fatigue, excessive sweat, weight loss, fever and weakness, making even simple tasks feel exhausting.

Tuberculosis (TB) is a serious infectious disease that primarily affects the lungs but can also impact other parts of the body. Despite being preventable and treatable, TB remains a leading cause of death across the world. The National Institute of Allergy and Infectious Diseases (NIAID) explains  the importance of understanding and addressing TB.

Story continues below Advertisement

Here are six essential facts about TB:

Also readTuberculosis returns as top infectious disease killer: WHO

  • Causes of TB and how it spreads:
  • According to the NIAID, TB is caused by the bacterium Mycobacterium tuberculosis (Mtb). It spreads through the air when someone with active TB of the lungs or throat coughs, speaks, or sings, releasing bacteria that others can inhale. Not everyone exposed to Mtb becomes sick; some may develop latent TB infection, where the bacteria remain inactive without causing symptoms or being contagious.

    2. Symptoms of TB

    Not everyone with TB bacteria gets sick. Many have latent TB with no symptoms and can't spread it, suggests WHO. But if TB becomes active, symptoms can take months to appear, making it easy to pass the infection without realising it. The most common signs include a long-lasting cough (sometimes with blood), chest pain, weakness, fatigue, weight loss, fever, and night sweats. TB mainly affects the lungs but can also spread to the kidneys, brain, spine, or skin, leading to different symptoms depending on the area infected.

    Also readChildhood lung diseases: Prevent asthma, tuberculosis, pneumonia with this detailed guide for parents

    3. Difference between latent TB and active TB disease:

    Story continues below Advertisement

    Those with latent TB carry the bacteria but don't exhibit symptoms and can't spread the disease. However, without treatment, latent TB can progress to active TB disease, especially in those with weakened immune systems. Active TB is symptomatic and contagious, requiring prompt medical attention.

    4. Risk factors:

    Certain health conditions can make you more likely to develop active TB. If you have diabetes, a weak immune system (such as from HIV/AIDS), poor nutrition, or habits like smoking and heavy drinking, your body may struggle to fight off TB bacteria. Babies and young children are also at higher risk since their immune systems are still developing.

    5. Global impact of TB:

    According to the World Health Organization (WHO), 1.25 million people died from tuberculosis (TB) in 2023, including 161,000 with HIV. TB has likely returned as the world's leading infectious disease killer, surpassing COVID-19. In 2023, around 10.8 million people fell ill with TB, affecting men, women, and children across all countries and age groups. TB is curable and preventable, yet drug-resistant TB remains a serious global health threat, with only 40 percent of affected patients receiving treatment. Since 2000, global efforts have saved 79 million lives, but $22 billion per year is needed to meet TB prevention and treatment goals by 2027. Ending TB by 2030 is part of the United Nations Sustainable Development Goals (SDGs).

    Also readTuberculosis can spread through air, follow these hygiene practices to prevent spread

    6. Challenges with drug-resistant TB:

    While effective treatments for TB exist, the emergence of drug-resistant strains poses significant challenges. These strains don't respond to standard medications, making infections harder to treat and control.

    Disclaimer: This article, including health and fitness advice, only provides generic information. Don't treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.

    Namita S Kalla is a senior journalist who writes about different aspects of modern life that include lifestyle, health, fashion, beauty, and entertainment.






    Comments

    Popular posts from this blog

    Blogs, Releases Address Impact Of COVID-19 On AIDS, TB, Malaria, Food Security Responses, Other Issues Related To Pandemic - Kaiser Family Foundation

    Compounds show promise in search for tuberculosis antibiotics - Science Daily

    Diseases A-Z List